Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Antioxidants for Prevention of Cataracts Follow-up Study

This study is enrolling participants by invitation only.
Aravind Eye Hospitals, India
Information provided by (Responsible Party):
University of California, San Francisco Identifier:
First received: August 10, 2012
Last updated: May 18, 2016
Last verified: May 2016

Aravind Eye Hospital and the University of California, San Francisco (UCSF) Proctor Foundation collaborated on the Antioxidants for the Prevention of Cataract Study from 1997-2002. (1) In the study, 798 participants aged 35-50 years were enrolled from 5 rural villages, and randomized to thrice weekly antioxidants (vitamin C, 500 mg; beta carotene, 15 mg; and alpha-tocopherol, 400 IU) or placebo. After 5 years of supplementation, there was no significant difference in cataract formation between the antioxidant group and placebo. In this follow-up study, we will return to study villages to determine whether rates of cataract surgery are different in the 2 groups.

1. Gritz DC, Srinivasan M, Smith SD, et al. The Antioxidants in Prevention of Cataracts Study: effects of antioxidant supplements on cataract progression in South India. The British journal of ophthalmology 2006;90:847-51.

Condition Intervention
Dietary Supplement: Antioxidant
Dietary Supplement: Placebo

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Investigator)
Primary Purpose: Prevention
Official Title: Antioxidants for Prevention of Cataracts Follow-up Study

Resource links provided by NLM:

Further study details as provided by University of California, San Francisco:

Primary Outcome Measures:
  • Cataract surgery [ Time Frame: 15 years post-intervention ]
    Effect of intervention on cataract surgery 15 years post-intervention in a logistic regression model

Secondary Outcome Measures:
  • Risk factors for cataract surgery [ Time Frame: 15 years post-intervention ]
    Association of risk factors assessed via questionnaire 15 years ago with cataract surgery in a multiple logistic regression model

  • All-cause mortality [ Time Frame: 15 years post-intervention ]

Estimated Enrollment: 798
Study Start Date: July 2012
Estimated Study Completion Date: May 2017
Estimated Primary Completion Date: February 2017 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Antioxidant supplementation
Randomized to receive antioxidant supplementation (vitamin C, 500 mg; beta carotene, 15 mg; and alpha-tocopherol, 400 IU) three times per week for five years.
Dietary Supplement: Antioxidant
Placebo Comparator: Placebo
Randomized to receive placebo three times per week for five years
Dietary Supplement: Placebo


Ages Eligible for Study:   50 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • participation in previous cataract study

Exclusion Criteria:

  • refusal to participate
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01664819

Aravind Eye Hospitals
Madurai, Tamil Nadu, India
Sponsors and Collaborators
University of California, San Francisco
Aravind Eye Hospitals, India
Principal Investigator: Jeremy D Keenan, MD, MPH University of California, San Francisco
Principal Investigator: Muthiah Srinivasan, MD Aravind Eye Hospitals
  More Information

Responsible Party: University of California, San Francisco Identifier: NCT01664819     History of Changes
Other Study ID Numbers: P0047247
Study First Received: August 10, 2012
Last Updated: May 18, 2016

Additional relevant MeSH terms:
Lens Diseases
Eye Diseases
Molecular Mechanisms of Pharmacological Action
Protective Agents
Physiological Effects of Drugs processed this record on May 25, 2017